REPLIGEN CORP

WALTHAM, MA How do I update this listing?

Repligen Corp is based out of Waltham. Repligen Corp. develops novel therapeutics for the treatment of diseases of the central nervous system. The company markets Protein A products which are used in the production of monoclonal antibodies, and SecreFlo, used as an aid in the diagnosis of certain pancreatic disorders.Whalewisdom has at least 126 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2019-06-13. The notice included securities offered of Equity

Create Alert

Contact Info

repligen corp
41 SEYON STREET
WALTHAM MA    02453

Business Phone: 7814499560
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2019-06-13 D OTHER HEALTH CARE Equity 48,000,000 48,000,000 0
2017-08-08 D OTHER HEALTH CARE Equity 238,590,580 238,590,580 0
2014-06-16 D OTHER TECHNOLOGY Equity 4,000,000 4,000,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALFRED L. GOLDBERG subscription required
    DIRECTOR
ANTHONY HUNT subscription required
    EXECUTIVE OFFICER
DANIEL P. WITT subscription required
    EXECUTIVE OFFICER
GLENN L. COOPER subscription required
    DIRECTOR
GLENN P. MUIR subscription required
    DIRECTOR
HOWARD BENJAMIN subscription required
    EXECUTIVE OFFICER
JAMES R. RUSCHE subscription required
    EXECUTIVE OFFICER
JOHN G. COX subscription required
    DIRECTOR
JON K. SNODGRES subscription required
    EXECUTIVE OFFICER
KAREN A. DAWES subscription required
    DIRECTOR
MICHAEL A. GRIFFITH subscription required
    DIRECTOR
NICOLAS BARTHELEMY subscription required
    DIRECTOR
RALF J. KURIYEL subscription required
    EXECUTIVE OFFICER
THOMAS F. RYAN , JR. subscription required
    DIRECTOR
THOMAS F. RYAN, JR. subscription required
    DIRECTOR
TONY J. HUNT subscription required
    EXECUTIVE OFFICER DIRECTOR
WALTER C. HERLIHY subscription required
    EXECUTIVE OFFICER DIRECTOR

Elevate your investments